The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations

Center for Vascular Pathology, Moscow

Status: Unknown

Conditions: Surgery; Vascular Malformations; Children, Only; Drug Effect

Treatments: Drug: Detralex; Drug: Troxevasin

Study type: Observational

Funder types: Other

Identifiers

NCT05113420

VAC_VM

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy and safety of different phlebotonic drugs in children and to assess patient satisfaction after treatment.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 1 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: venous malformation

• venous malformation

Exclusion Criteria:

• allergy

Trial design

1,000 participants in 4 patient groups

Per os+topical solution(1)

Treatment:

Drug: Detralex

Per os+topical solution(2)

Treatment:

Drug: Troxevasin

Drug: Detralex

Per os only

Treatment:

Drug: Detralex

Topical solution only

Treatment:

Drug: Troxevasin

Drug: Detralex